Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Oct;62(4):655-9.
doi: 10.1038/bjc.1990.350.

Long-term sequelae of treatment for testicular germ cell tumours

Affiliations
Free PMC article

Long-term sequelae of treatment for testicular germ cell tumours

D Bissett et al. Br J Cancer. 1990 Oct.
Free PMC article

Abstract

Seventy-four patients previously treated in our department for germ cell tumour of the testis underwent a series of tests to determine the frequency of long-term therapeutic complications. All had received cisplatin-based chemotherapy as part of their treatment. There was a significant deterioration in renal function throughout the group. Eighteen (24%) had supine blood pressure greater than systolic 140 mmHg or diastolic 90 mmHg after treatment but hypertension did not correlate with renal impairment. Raynaud's phenomenon was common after chemotherapy (26/74) as was persistent sensory neuropathy (23/74). Although 34% had testosterone levels below the normal range, only six patients had a low free testosterone index with one testis still in situ; 18 patients have fathered children after chemotherapy. Approximately half of the patients completed a psychosexual questionnaire and some 30% of them admitted to sexual problems which they attributed to their treatment. Long-term sequelae of cisplatin-based chemotherapy for testicular malignancy are frequent and persistent, and follow-up of these patients should include prospective measurement of changes in blood pressure.

PubMed Disclaimer

References

    1. J Clin Oncol. 1988 Aug;6(8):1216-9 - PubMed
    1. Semin Oncol. 1988 Aug;15(4):345-50 - PubMed
    1. Eur J Cancer Clin Oncol. 1989 Feb;25(2):185-9 - PubMed
    1. J Laryngol Otol. 1970 Jan;84(1):41-63 - PubMed
    1. Ann Intern Med. 1981 Sep;95(3):288-92 - PubMed

MeSH terms

Substances